Canadian family physicians' and paediatricians' knowledge, attitudes and practices regarding A(H1N1) pandemic vaccine

被引:30
作者
Dubé E. [1 ,2 ]
Gilca V. [1 ,2 ]
Sauvageau C. [1 ,2 ]
Boulianne N. [1 ,2 ]
Boucher F.D. [1 ]
Bettinger J.A. [3 ]
McNeil S. [4 ]
Gemmill I. [5 ]
Lavoie F. [1 ]
Ouakki M. [2 ]
机构
[1] Centre de Recherche du CHUL-CHUQ, Centre Hospitalier de l'Université Laval, QC
[2] Institut National de Santé Publique du Québec, QC
[3] University of British Columbia, Vaccine Evaluation Center, BC Children's Hospital, Vancouver, BC
[4] Canadian Center for Vaccinology, Halifax, NS
[5] Kingston, Frontenac and Lennox and Addington Public Health Unit, Kingston, ON
关键词
Influenza; Family Physician; Healthcare Worker; Seasonal Influenza; Pandemic Influenza;
D O I
10.1186/1756-0500-3-102
中图分类号
学科分类号
摘要
Background: One of the main determinants of public immunization success is health professionals' support and recommendations. Little is known about the physicians' level of support and intentions regarding A(H1N1) pandemic influenza vaccination. The aim of this survey was to document Canadian family physicians' and paediatricians' knowledge, attitudes and practices (KAP) as well as their intentions regarding A(H1N1) pandemic influenza vaccines right before the beginning of the largest immunization campaign in Canadian history. Findings. A self-administered, anonymous, mail-based questionnaire was sent to a random sample of family physicians and to all paediatricians practicing in Canada. All 921 questionnaires received by October 29 2009 were included in the analysis. Between 72% and 92% of respondents agreed with the statements regarding vaccine safety, effectiveness and acceptability. More than 75% of respondents intended to recommend the A(H1N1) pandemic influenza vaccine to their patients and to get vaccinated themselves. The most significant factors associated with the intention to recommend A(H1N1) pandemic vaccines were physicians' intention to be vaccinated against influenza themselves and the perceived acceptability of the vaccine by the vaccinators. Conclusions. Most Canadian family physicians and paediatricians surveyed were supportive of the A(H1N1) pandemic influenza vaccination before its implementation and large media coverage. © 2010 Dubé et al; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 26 条
[1]  
Chan M., World Now at the Start of 2009 Influenza Pandemic, (2009)
[2]  
Zivkovic Gojovic M., Sander B., Fisman D., Krahn M.D., Bauch C.T., Modelling mitigation strategies for pandemic (H1N1) 2009, CMAJ, Early Release Published at
[3]  
Nuno M.C.G., Gumel A.B., Assessing the role of basic control measures, antivirals and vaccine in curtailing pandemic influenza: Scenarios for the US, UK and Netherlands, J R Soc Interface, 4, pp. 505-521, (2007)
[4]  
Sypsa V., Pavlopoulou I., Hatzakis A., Use of an inactivated vaccine in mitigating pandemic influenza A(H1N1) spread: A modelling study to assess the impact of vaccination timing and prioritisation strategies, Euro Surveill, 14, 41, (2009)
[5]  
Maurer J., Et al., Does receipt of seasonal influenza vaccine predict intention to receive novel H1N1 vaccine: Evidence from a nationally representative survey of U.S. adults, Vaccine, 27, 42, pp. 5732-4, (2009)
[6]  
Lau J.T.F., Yeung N.C.Y., Choi K.C., Cheng M.Y.M., Tsui H.Y., Griffiths S., Acceptability of A/H1N1 vaccination during pandemic phase of influenza A/H1N1 in Hong Kong: Population based cross sectional survey, BMJ, 2009, 339, (2009)
[7]  
Seale H., McLaws M.L., Heywood A.E., Ward K.F., Lowbridge C.P., Van D., Gralton J., MacIntyre C.R., The community's attitude towards swine flu and pandemic influenza, The Medical Journal of Australia, 191, 5, pp. 267-269, (2009)
[8]  
Lagarde F., Summary of Public Opinion on Immunization in Canada, (2005)
[9]  
Brewer N.T., Fazekas K.I., Predictors of HPV vaccine acceptability: A theory-informed, systematic review, Preventive Medicine, 45, 2-3, pp. 107-114, (2007)
[10]  
Zimet G.D., Liddon N., Rosenthal S.L., Lazcano-Ponce E., Allen B., Chapter 24: Psychosocial aspects of vaccine acceptability, Vaccine, 24, SUPPL. 3, (2006)